Literature DB >> 16943456

Comparison of low-fat meal and high-fat meal on postprandial lipemic response in non-obese men according to the -1131T>C polymorphism of the apolipoprotein A5 (APOA5) gene (randomized cross-over design).

Ji Young Kim1, Oh Yoen Kim, Soo Jeong Koh, Yangsoo Jang, Sung-Seob Yun, Jose M Ordovas, Jong Ho Lee.   

Abstract

OBJECTIVE: The purpose of this study was to compare low-fat (LF) meal and high-fat (HF) meal on the postprandial lipemic responses according to the -1131T>C polymorphism of the APOA5 gene in a population usually consuming a LF diet and having a high frequency of the variant allele at the APOA5 -1131T>C SNP.
METHODS: This study was conducted using a cross-over design and 49 non-obese healthy men (42.8 +/- 0.7 yrs, 23.9 +/- 0.25 kg/m(2)) participated in the meal tolerance test. They were randomly assigned to consume one of two types of experimental enteral formulae (LF vs HF) with a seven-day interval. Blood samples were collected at 0, 2, 3, 4 and 6h after ingestion and analyzed for total and chylomicron TG, glucose, insulin and free fatty acid.
RESULTS: No differences were found in anthropometic parameter, calorie and macronutrient intakes and total energy expenditure between TT (n = 23) and TC + CC (n = 26) men. Fasting total TG were higher in TC + CC men than TT men, but fasting chylomicron TG were not significantly different between TT men and C carriers, TT subjects had no significant differences in postprandial responses of total TG and chylomicron TG and postprandial mean changes of chylomicron TG between LF and HF meal. On the other hand, C carriers had delayed peak time of total TG compared to TT subject and higher postprandial response and mean changes of chylomicron TG at HF meal compared to LF meal.
CONCLUSION: The capacity to clear chylomicron-TG or hydrolyze TG might become a rate-limiting factor on HF diet in TC + CC men resulting in higher postprandial triglyceridemia. Therefore, HF diet for C carriers of the APOA5 gene may be one of important CVD risk factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943456     DOI: 10.1080/07315724.2006.10719544

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  12 in total

1.  APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population.

Authors:  Carmen Sánchez-Moreno; Jose M Ordovás; Caren E Smith; Juan C Baraza; Yu-Chi Lee; Marta Garaulet
Journal:  J Nutr       Date:  2011-01-05       Impact factor: 4.798

2.  Association of the APOA-5 Genetic Variant rs662799 with Metabolic Changes after an Intervention for 9 Months with a Low-Calorie Diet with a Mediterranean Profile.

Authors:  Daniel de Luis Roman; David Primo; Olatz Izaola; Rocio Aller
Journal:  Nutrients       Date:  2022-06-11       Impact factor: 6.706

3.  APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial.

Authors:  Xiaomin Zhang; Qibin Qi; George A Bray; Frank B Hu; Frank M Sacks; Lu Qi
Journal:  Am J Clin Nutr       Date:  2012-08-22       Impact factor: 7.045

4.  Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults.

Authors:  Josiemer Mattei; Serkalem Demissie; Katherine L Tucker; Jose M Ordovas
Journal:  J Nutr       Date:  2009-10-14       Impact factor: 4.798

Review 5.  Clinical significance of apolipoprotein A5.

Authors:  E Shyong Tai; Jose M Ordovas
Journal:  Curr Opin Lipidol       Date:  2008-08       Impact factor: 4.776

6.  Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach.

Authors:  Maira Ladeia R Curti; Patrícia Jacob; Maria Carolina Borges; Marcelo Macedo Rogero; Sandra Roberta G Ferreira
Journal:  J Obes       Date:  2011-05-23

7.  Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency.

Authors:  Mikio Takanashi; Takeshi Kimura; Chengcheng Li; Masaki Tanaka; Ako Matsuhashi; Hiroki Yoshida; Akari Noda; Pengfei Xu; Satoru Takase; Sachiko Okazaki; Yoko Iizuka; Hidetoshi Kumagai; Yuichi Ikeda; Takanari Gotoda; Manabu Takahashi; Hiroaki Yagyu; Shun Ishibashi; Toshimasa Yamauchi; Takashi Kadowaki; Guosheng Liang; Hiroaki Okazaki
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

8.  The association between APOA5 haplotypes and plasma lipids is not modified by energy or fat intake: the Czech HAPIEE study.

Authors:  J A Hubacek; A Peasey; R Kubinova; H Pikhart; M Bobak
Journal:  Nutr Metab Cardiovasc Dis       Date:  2013-10-09       Impact factor: 4.222

9.  Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes.

Authors:  Ryungwoo Kang; Minjoo Kim; Jey Sook Chae; Sang-Hyun Lee; Jong Ho Lee
Journal:  Trials       Date:  2014-04-01       Impact factor: 2.279

10.  Effects of a 3-year dietary intervention on age-related changes in triglyceride and apolipoprotein A-V levels in patients with impaired fasting glucose or new-onset type 2 diabetes as a function of the APOA5 -1131 T > C polymorphism.

Authors:  Minjoo Kim; Jey Sook Chae; Miri Kim; Sang-Hyun Lee; Jong Ho Lee
Journal:  Nutr J       Date:  2014-04-28       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.